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Abstract 
Introduction: 63% of hypertensive patients have evidence of hypertensive angiopathy. 
Increase of effectiveness of drug therapy of retinal angiopathy of hypertensive type is an 
important task of pharmacology. 
Objectives: To increase the effectiveness of pharmacological correction of retinal 
angiopathy of hypertensive type using a new dimethylaminoethanol (DMAE) derivative 
19-16.  
Materials and Methods: We studied protective effects of DMAE derivative 19-16 in 
doses 25 mg/kg, 50 mg/kg on a model of retinal angiopathy of hypertensive type on 
Wistar male rats, which was carried out by N-nitro-L-arginine-methyl ester (L-NAME) 
introducing in a dose 12.5 mg/kg/day within 28 days. To study the fundus of 
experimental animals, direct ophthalmoscopy was used. Electroretinography (ERG) was 
recorded in response to a single stimulation. The induced biopotentials were amplified, 
averaged and presented graphically with the help of Biopac-systems MP-150 with the 
program AcqKnowledge 4.2 (USA). To assess the degree of development of functional 
damage to the retina, the ratio of the amplitudes of the b- and a-waves, the coefficient 
b/a, was estimated. 
Results and Discussion: DMAE derivative 19-16 in a dose 50 mg/kg prevented the 
development of ischemic damage and retinal vascular changes caused by introduction of 
L-NAME, to a greater extent than in a dose 25 mg/kg. The observed retinoprotective 
effects are confirmed by ophthalmoscopy and ERG.  
Conclusion: The search of new ways of correction of the retinal angiopathy as a 
complication of hypertension is an urgent task of pharmacology, which can be solved by 
using a new DMAE derivative 19-16. 
Keywords: retinal angiopathy of hypertensive type, dimethylaminoethanol derivatives, 
ophthalmoscopy, electroretinography. 
 
Introduction  
The picture of the fundus and indicators of 
local hemodynamics significantly complement 
the representation of researchers about the 
features of the disease, can detect early signs of 
organic changes in the retinal vessels and judge 
by their state with a certain degree of 
confidence about the changes of regional 
vascular bed and on the vascular system of the 
body as a whole [1].  
Hypertension, existing for a long time, 
leads to serious complications in retina. 63% of 
hypertensive patients have evidence of 
hypertensive angiopathy [2]. Hypertensive 
angiopathy is characterized by the first phase of 
hypertension, in which there are only functional 
vascular disorders and the pressure is unstable. 
The above changes in the retina, of course, lead 
to disruption of blood supply and the 
development of ischemic conditions. 
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The search for innovative molecules [3, 4] 
is an important task of pharmacology. 
Moreover, their study should be carried out in 
vivo models [5, 6]. 
 Derivatives of DMAE (precursors of 
acetylcholine) are classified as nootropic 
agents. In ophthalmology, in the complex 
treatment of retinal vascular diseases, the 
nootropic drugs are used, for example, 
nicotinoyl-GABA, ginkgo biloba, vinpocetine. 
In the treatment of retinal angiopathy of 
hypertensive type antihypertensive drugs, 
symptomatic treatment are used, which do not 
always allow to achieve the desired result. 
Therefore, increasing the effectiveness of 
pharmacological correction of retinal 
angiopathy of hypertensive type is an important 
task of pharmacology and ophthalmology. 
In connection with the foregoing, it should 
be noted the relevance of studying the 
protective properties of new DMAE derivative 
19-16 on the model of retinal angiopathy of 
hypertensive type in experiment. 
Objectives  
To increase the effectiveness of 
pharmacological correction of retinal 
angiopathy of hypertensive type using a new 
DMAE derivative 19-16. 
 
Materials and Methods  
Experiments were carried out on Wistar 
male rats weighing 225-275 g.  The rats were 
taken for the study with no external signs of 
disease, passed quarantine regime. Ethical 
principles of handling laboratory animals are 
observed in accordance with the «European 
Convention for the Protection of Vertebral 
Animals Used for Experimental and Other 
Scientific Purposes. CETS No. 123». 
Manipulations were performed on rats under 
general anesthesia by intraperitoneal (i/p) 
introducing an aqueous solution of chloral 
hydrate in a dose 300 mg/kg. 
The study includes the following groups: 
first (n = 10) – the group of intact animals, 
second (n = 10) – the group with the 
modeling of retinal angiopathy (control), 
third (n = 10) – the correction of pathology 
by DMAE derivative 19-16 in a dose 25 mg/kg, 
fourth (n = 10) – the correction of 
pathology by DMAE derivative 19-16 in a dose 
50 mg/kg. 
L-NAME was injected in a dose  
12.5 mg/kg/day within 28 days i/p daily [7]. 
DMAE derivative 19-16 was administered 
to rats in the solution form in doses 25 
mg/kg/day and 50 mg/kg/day intragastrically 
(i/g) for 60 min prior to administration of  
L-NAME daily for 28 days. 
To measure blood pressure in rats (tail) 
a system of non-invasive measurement of 
blood pressure for small animals NIBP200 
was used in the complex Biopac-systems  
MP-150. 
To study the fundus in experimental 
animals, direct ophthalmoscopy was used on 
the 29
th
 day of the experiment (Bx a Neitz 
ophthalmoscope, Japan). To expand the 
pupil, eye drops Irifrin 2.5% were used. The 
ophthalmoscope was approached to the rat`s 
eye and sent a beam of light at a distance of 
0.5-2 cm to obtain a clear picture of the 
fundus. To increase the image, the lens 
Osher MaxField 78D model OI-78M was 
used [8]. 
ERG was performed at once after 
ophthalmoscopy. For this purpose, the 
animals were kept in the dark within 30 min 
[9], then anesthetized and fixed on a table. 
The corneal silver electrode was placed on 
the cornea, the reference needle electrode 
EL452 was placed subcutaneously in the 
skull region, the ground needle electrode 
EL450 was placed in the base of the tail. A 
stroboscope with a flash of white light, 
connected to the stimulator STM200 by 
Biopac System, Inc. (USA) were placed 
behind the animal back; the ERG was 
recorded in response to a single stimulation. 
The induced biopotentials were amplified, 
averaged and presented graphically on the 
screen with help of Biopac-systems MP-150 
and program AcqKnowledge 4.2 (USA). To 
evaluate the degree of development of 
functional retinal damage, the ratio of the 
amplitudes of the b- and a-waves of the 
ERG, the coefficient b/a, was estimated [10]. 
From the 10 values obtained in each group, 
the output was the average value, which was 
recorded in the protocol. 
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For all data, the descriptive statistics 
were applied: the data were checked for the 
normality of the distribution. The type of 
distribution was determined by the Shapiro-
Wilk criterion. In the case of a normal 
distribution, the average value (M) and the 
standard error of the mean (m) were 
calculated. In cases of abnormal distribution, 
the median (Me) and the quarterly range 
(QR) were calculated. Intergroup differences 
were analyzed by parametric (Student's t-
test) or nonparametric (Mann-Whitney test) 
methods, depending on the distribution type. 
Differences were determined at 0.05 
significance level. Statistical analysis is 
performed using the software Statistica 10.0. 
Results and discussion. We used a model 
of retinal angiopathy of hypertensive type, 
which pathogenesis is associated with the 
development of hypertension in rats on the 
background of daily i/p administration of  
L-NAME in a dose 12.5 mg/kg/day for 28 days 
[7] (SBP 204.8 mmHg, DBP 164.2 mmHg in a 
group with pathology; SBP 139.2 mmHg, DBP 
104.2 mmHg in the intact group, p<0.05). The 
confirmation of the formation of vascular 
changes of hypertensive type in the retina were 
results of ophthalmoscopy and ERG on the 29
th
 
day of the experiment. 
In accordance with the protocol the 
anesthesia of animals was carried out on 29
th
 
day of the experiment. 
Example of ophthalmoscopy on intact 
animal is shown in fig. 1.  
 
 
 
 
Fig. 1. Example of ophthalmoscopy on intact Wistar rat. Optic disc is circular or oval shape 
and stands out from the fundus in pale – pink. The boundaries of the optic nerve disc are clear. It lies 
in the plane of the retina. From the middle of the optic nerve exit the central vessels of the retina. 
Blood vessels of the retina don`t have anastomoses. The veins and arteries are straightforward, caliber 
is uniform, not crimped. The general background is pink 
 
Example of ophthalmoscopy on animal 
with retinal angiopathy of hypertensive type is 
shown in fig. 2. 
In the group with correction by DMAE 
derivative 19-16 in a dose 25 mg/kg/day it was 
found during ophthalmoscopy: optic disc is 
circular or oval in shape and stands out from 
the fundus in pale – pink. The boundaries of the 
optic nerve disc are clear. There is a slight 
vasoconstriction, "the phenomenon of chiasm", 
a symptom Salus-Hun I. Veins are crimped at 
the periphery. The background is slightly paly. 
Example of ophthalmoscopy on animal 
with correction by DMAE derivative 19-16 in a 
dose 50 mg/kg/day is shown in fig. 3. 
The results of the electrophysiological 
activity evaluation of rat retina on day 29 of the 
experiment are presented in tab. 1. 
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Fig. 2. Example of ophthalmoscopy on Wistar rat with retinal angiopathy of hypertensive type 
(control). Optic disc is circular or oval shape and stands out from the fundus in pink. The boundaries  
of the optic nerve disc are clear. Veins are congested, full-blooded, crimped at the periphery. Arteries 
are narrowed, slightly crimped. Retina is palely (ischemic). Symptom Salus-Hun I 
 
 
Fig. 3. Example of ophthalmoscopy on animal with correction by DMAE derivative 19-16 in  
a dose 50 mg/kg/day. Optic disc is circular or oval shape and stands out from the fundus in pale – pink. 
The boundaries of the disc are clear. Blood vessels of the retina don`t have anastomoses.   
The veins and arteries are straightforward, no crimping. Veins are slightly dilated.  
The general background is pink, not ischemic 
Table 1 
Results of electroretinography on day 29
th
 of the experiment (M ± m; n = 10), r.u. 
 
Experimental groups b/a 
Intact 2,6±0,07у 
Control 2,2±0,05* 
Correction by DMAE derivative 19-16, 25 mg/kg/day 2,4±0,06*у 
Correction by DMAE derivative 19-16, 50 mg/kg/day 2,5±0,08 у   
Note: * – p<0.05 compared with the group of intact animals, у – р<0.05 compared with the control 
group
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Thus, the results of fundus studies and 
ERG in experimental groups revealed 
pronounced protective properties of the DMAE 
derivative 19-16 in a dose 50 mg/kg/day, 
exceeding its effect in a dose 25 mg/kg/day, 
consisting in a reduction in the development of 
vascular changes in the retina on the 
background of arterial hypertension, which 
were noted in the control group; an increase in 
the coefficient b/a in the groups with the 
correction of pathology, which is caused by the 
restoration of the positive wave b on the ERG 
and indicates the preservation of the 
electrophysiological function of the bipolar and 
müllerian cells. 
The main factors in the development of 
retinal angiopathy of hypertensive type are 
disorders of common hemodynamics, local 
changes in the vessel walls. From local changes 
are the most important violations of the 
vascular endothelium [11].  
In this regard, there is a need to find new 
methods of retinoprotection for possible 
reduction of the damaging effect of ischemia, 
formed in the retinal angiopathy of 
hypertensive type. Segment of drugs for the 
treatment of vascular diseases of the eye as a 
complication of systemic diseases is expedient 
to expand due to the increasing of incidence 
and lack of funds for targeted correction of 
ischemic lesions of the eye vessels [12]. 
Based on the fact that electrophysiological 
studies often have a decisive importance in the 
early and differential diagnosis of retinal 
disorders [13], to study the correction of 
functional changes in the retina, researcher 
must conduct a comprehensive analysis, 
including ophthalmoscopic, 
electroretinography, microcirculation research. 
Current literature data indicate the 
effective use of nootropics in ophthalmic 
practice: clinical and functional examinations 
showed a faster and more stable improvement 
in visual acuity in the group of patients with 
chronic ocular ischemic syndrome with the use 
of choline alfoscerate [14]; the use of citicoline 
has shown a positive effect in the treatment of 
amblyopia and improves the function of the 
retina [15, 16]; vinpocetine modulates 
metabolic activity and function during retinal 
ischemia [17], etc. 
Angiopathy of the retina of hypertensive 
type is correlated with a high risk of cardio – 
vascular diseases in general, but not included in 
the risk assessment tools. Currently abroad the 
research of hypertensive retinopathy as 
determinant of target organ damage in 
hypertension are actively conducted [18, 19, 
20]. 
In connection with the foregoing, the study 
of the protective properties of the new DMAE 
derivative 19-16 on the model of retinal 
angiopathy of hypertensive type in the 
experiment was topical. 
Conclusion  
Results of ocular fundus studies revealed 
the most pronounced protective effect of the 
new DMAE derivative 19-16 in a dose 50 
mg/kg/day on the model of retinal angiopathy 
of hypertensive type in Wistar male rats. 
Correction of retinal angiopathy of 
hypertensive type by DMAE derivative 19-16 
in a dose 50 mg/kg/day leads to higher values 
of the coefficient b/a of ERG on the 29
th
 day of 
the experiment compared to the group with 
correction by DMAE derivative 19-16 in a dose 
25 mg/kg/day, which indicates the restoration 
of the electrophysiological state of the retina. 
 
Conflicts of interest 
The authors have no conflict of interest to 
declare. 
 
References 
1. Savina YN, Dolgikh VV, Pogodin 
AV, et al. The early manifestations of 
hypertensive angiochorioretinopathy in 
adolescents with essential hypertension. 
Ophthalmosurgery. 2014;3:48-52. (in Russian) 
[Full text] 
2. Stepushina OA. Study of the 
diagnostic capabilities of combined use of 
adaptive optics and method of retinal vascular 
calibrometry [dissertation]. [Moscow]: 
Research Institute of Eye Diseases; 2012. 96 p. 
(in Russian) [eLIBRARY] [Full text] 
3. Beskhmelnitsyna EA, Kravchenko 
DV, Pokrovsky MV, et al. Molecular screening 
for potential selective antagonists of TRPA1 
ion channel. The Bulletin of the Scientific 
Centre for Expert Evaluation of Medicinal 
Products. 2016;7(3):186-189. [Full text] 
 
Peresypkina А.А. Correction of retinal angiopathy of hypertensive type by 
dimethylaminoethanol derivative 19-16 in experiment. Research Results in Pharmacology. 
2017;3(4):113-119. 
118 
 
December. 2017. 3(4). Research Results in Pharmacology  rrpharmacology.ru 
4. Bogus SK, Galenko-Yaroshevsky PA, 
Dukhanin AS, Shimanovsky NL. Effect of 
indole derivatives ss-68 having antiarrhythmic 
and antianginal properties on α 1-, β 1-and β 2 
adrenergic receptors. New Technologies. 
2012;4: 232-235. [eLIBRARY] 
5. Martynova OV, Zhilinkova LA, 
Gureev VV, Martynov MA, Beskhmelnitsyna 
EA, Kostina DA, Anciferov OV, Shkileva IY. 
Research of behavioural reactions when 
modelling the total ischemia of the brain. 
Kubanskij nauchnyj medicinskij vestnik. 
2015;6(155):77-82. [eLIBRARY] [Full text] 
6. Pokrovskiy MV, Korokin MV, 
Tsepeleva SA, et al. Arginase inhibitor in the 
pharmacological correction of endothelial 
dysfunction. International Journal of 
Hypertension. 2011. art. no. 515047. [Scopus] 
7. Peresypkina AA, Gubareva VO, 
Levkova EA, Shabelnikova AS. Correction of 
retinal angiopathy of hypertensive type by 
minoxidil, sildenafil in experiment. Research 
result: pharmacology and clinical 
pharmacology. 2016;2(4):34-44. DOI: 
10.18413/2500-235X-2016-2-4-34-44. [Full 
text] 
8. Peresypkina AA, Pazhinsky AL, 
Pobeda AS, Dolzhikov AA, Zhernakova NI, 
Osipova OA, Grigorenko AP, Ruzhenkov VA. 
The development of hypertensive 
neuroretinopathy model. Indo Am. J. P. Sci. 
2017;4(10):3695-3700. DOI: 
10.5281/zenodo.1019416. [Full text] 
9. Zahng L, Gu Y-h, An J, et al. Effects 
of the duration of dark adaptation on the retinal 
function of normal SD rats. Chinese journal of 
optometry ophthalmology and visual science. 
2013;15(6):323-326. [Abstract] 
10. Bowles K, Cukras C, Turriff A, et al. 
X-linked retinoschisis: RS1 mutation severity 
and age affect the ERG phenotype in a cohort 
of 68 affected male subjects. Invest Ophthalmol 
Vis Sci. 2011;52(12):9250-9256. DOI: 
10.1167/iovs.11-8115. [Full text] 
11. Tinjust D, Kergoat H, Lovasik JV. 
Neuroretinal function during mild systemic 
hypoxia. Aviat. Space Environ. Med. 
2002;73(12):1189-1194. [PubMed] 
12. Arustamova AA, Pokrovskiy MV, 
Shabelnikova AS, et al. Analysis of the Russian 
wholesale market of eye drops for 2006 – 1-3 
sq. 2012. Russian medical–biological 
messenger named after I.P. Pavlov. 2013;4:71-
76. [Full text] 
13.  Zhiqing C, Ke Y, Wen X, et al. 
Inhibition of synthesis of calpain by inhibitor 
E-64d in the retina subjected to 
ischemia/reperfusion. Molecular Biology. 
2008;42(2):258-264. [Full text] 
14.  Kamilov KM, Kasimova MS, 
Makhkamova DK. Analysis of choline 
alfoscerate effectiveness in chronic ocular 
ischemic syndrome. Vestn Oftalmol. 
2016;132(2):73-76. [PubMed] 
15.  Roberti G, Tanga L, Michelessi M, et 
al. Cytidine 5'-Diphosphocholine (Citicoline) in 
Glaucoma: Rationale of Its Use, Current 
Evidence and Future Perspectives. Int J Mol 
Sci. 2015;16(12):28401-28417. DOI: 
10.3390/ijms161226099. [PubMed] 
16.   Parisi V, Centofanti M, Ziccardi L, et 
al. Treatment with citicoline eye drops 
enhances retinal function and neural conduction 
along the visual pathways in open angle 
glaucoma. Graefes Arch Clin Exp Ophthalmol. 
2015;253(8):1327-40. DOI: 10.1007/s00417-
015-3044-9. [PubMed] 
17.  Nivison-Smith L, O'Brien BJ, Truong 
M, et al. Vinpocetine modulates metabolic 
activity and function during retinal ischemia. 
Am J Physiol Cell Physiol. 2015;308(9):737-
749. DOI: 10.1152/ajpcell.00291.2014. 
[PubMed] 
18. Kolman SA, van Sijl AM, van der 
Sluijs FA, van de Ree MA. Consideration of 
hypertensive retinopathy as an important end-
organ damage in patients with hypertension. J 
Hum Hypertens. 2017;31(2):121-125. DOI: 
10.1038/jhh.2016.49 [PubMed] 
19. Cuspidi C, Meani S, Valerio C, et al. 
Prevalence and correlates of advanced 
retinopathy in a large selected hypertensive 
population. The Evaluation of Target Organ 
Damage in Hypertension (ETODH) study. 
Blood Press. 2005; 14(1):25-31. [PubMed] 
20. Cuspidi C, Macca G, Salerno M, et al. 
Evaluation of target organ damage in arterial 
hypertension: which role for qualitative 
 
Peresypkina А.А. Correction of retinal angiopathy of hypertensive type by 
dimethylaminoethanol derivative 19-16 in experiment. Research Results in Pharmacology. 
2017;3(4):113-119. 
119 
 
December. 2017. 3(4). Research Results in Pharmacology  rrpharmacology.ru 
funduscopic examination? Ital Heart J. 
2001;2(9):702-706. [PubMed] 
 
Contributors 
Anna A. Peresypkina, Candidate of 
Biological Sciences, Associate Professor, 
Department of Pharmacology and Clinical 
Pharmacology, Institute of Medicine. E-mail: 
peresypkina_a@bsu.edu.ru. The author carried 
out  experimental   work,  statistical  processing 
and evaluation of retinoprotective activity in 
the experiment, conducted analysis and 
interpretation of the results. 
 
 
Received: September, 15, 2017 
Accepted: November, 30, 2017 
Available online: December, 30, 2017 
